Published in J Affect Disord on February 01, 1983
Serotonergic dysfunction in patients with bipolar disorder assessed by the loudness dependence of the auditory evoked potential. Psychiatry Investig (2012) 0.89
The presence of neurological soft signs along the psychosis proneness continuum. Schizophr Bull (2006) 0.86
Prefronto-cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder. Neuropsychiatr Dis Treat (2015) 0.79
Neurobiological characterization of bipolar affective disorders : a focus on tardive dyskinesia and soft neurological signs in relation to serum dopamine Beta hydroxylase activity. Indian J Psychiatry (1998) 0.78
Neurological soft signs and cognitive functions: Amongst euthymic bipolar I disorder cases, non-affected first degree relatives and healthy controls. Asian J Psychiatr (2016) 0.76
Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS (1993) 1.87
Neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1992) 1.52
Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophr Res (1998) 1.32
Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Arch Gen Psychiatry (1986) 1.23
Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry (1990) 1.19
Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Compr Psychiatry (1993) 1.06
Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med (2012) 1.01
Corpus callosum thickness in chronic schizophrenia. Br J Psychiatry (1983) 0.98
Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model. Biol Psychiatry (1982) 0.98
Vulnerability to disulfiram psychosis. West J Med (1979) 0.98
Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Arch Gen Psychiatry (1982) 0.96
Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Arch Gen Psychiatry (1986) 0.95
A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia. Biol Psychiatry (1986) 0.93
A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Res (1983) 0.93
The unintegrated right cerebral hemispheric consciousness as alien intruder: a possible mechanism for Schneiderian delusions in schizophrenia. Compr Psychiatry (1985) 0.93
Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychol Med (1993) 0.92
Cortical atrophy in schizophrenia and mania: a comparative CT study. J Clin Psychiatry (1982) 0.92
Childhood head trauma and psychosis. Psychiatry Res (1987) 0.91
Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res (1986) 0.91
Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry (1993) 0.91
Lithium therapy and the risk for leukemia. Br J Psychiatry (1981) 0.91
Laterality shift in alcoholic males. Biol Psychiatry (1983) 0.90
Biparietal infarctions in a patient with Catatonia. Am J Psychiatry (1981) 0.90
Early computed tomographic abnormalities following profound cerebral hypoxia. Arch Neurol (1984) 0.90
Clinical effectiveness of oral and parenteral rapid neuroleptization. J Clin Psychiatry (1987) 0.90
Organic factors in catatonia. Br J Psychiatry (1986) 0.89
Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry (1990) 0.88
High alcoholism rate in patients with essential tremor. Am J Psychiatry (1982) 0.87
Neurodevelopmental aspects of bipolar affective disorder. Biol Psychiatry (1991) 0.87
Motor lateralization in manic males. Br J Psychiatry (1982) 0.86
Linkage analysis of schizophrenia in African-American families. Schizophr Res (2009) 0.86
Tardive dyskinesia in a phantom limb. Br J Psychiatry (1983) 0.85
Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. J Clin Exp Neuropsychol (1994) 0.83
Cerebellar atrophy in schizophrenia and mania. Lancet (1981) 0.83
TCA-induced mania: differences between switchers and nonswitchers. Biol Psychiatry (1982) 0.83
Perinatal insult as a risk factor in paranoid and nonparanoid schizophrenia. Psychopathology (1987) 0.83
Mania associated with electroconvulsive therapy. J Clin Psychiatry (1986) 0.82
Third and lateral ventricular volumes in schizophrenia: support for progressive enlargement of both structures. Psychopharmacol Bull (1990) 0.82
Perinatal distress and prognosis of psychotic illness. Neuropsychobiology (1987) 0.82
Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry Res (1995) 0.82
Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol (1997) 0.82
Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1993) 0.81
Propranolol and prolactin. Lancet (1977) 0.81
Modified leukotomy in the treatment of intractable obessional neurosis. Am J Psychiatry (1982) 0.81
Major depression and carbon monoxide-induced parkinsonism: diagnosis, computerized axial tomography, and response to L-dopa. J Nerv Ment Dis (1985) 0.81
The P50 evoked potential component and mismatch detection in normal volunteers: implications for the study of sensory gating. Psychiatry Res (1995) 0.80
Duration of illness and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1994) 0.80
Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole. Int J Obes (Lond) (2010) 0.80
Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS (1993) 0.80
Family history and brain morphology in schizophrenia: an MRI study. Psychiatry Res (1991) 0.80
Midsagittal cerebral anatomy by magnetic resonance imaging. The importance of slice position and thickness. Schizophr Res (1991) 0.79
Secondary depression in alcoholism: implications for future research. Compr Psychiatry (1982) 0.79
Depression, cortisol metabolism and lymphocytopenia. J Affect Disord (1985) 0.79
Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biol Psychiatry (1992) 0.79
Psychopathology of corpus callosum tumors. Biol Psychiatry (1981) 0.79
Correlation between plasma concentrations of chlorpromazine and clinical response. Commun Psychopharmacol (1978) 0.78
Effects of dopamine synthesis inhibition on WAIS comprehension. J Consult Clin Psychol (1978) 0.78
Postpartum mood disorders: clinical perspectives. J Womens Health (1997) 0.78
Hemispheric asymmetries on computed tomographic scans in schizophrenia and mania. A controlled study and a critical review. Arch Gen Psychiatry (1983) 0.78
Neuropsychological deficit in schizophrenic subtypes: paranoid, nonparanoid, and schizoaffective subgroups. Psychiatry Res (1990) 0.78
Magnetic resonance imaging of white matter lesions in HIV infection. J Neuropsychiatry Clin Neurosci (1992) 0.77
Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. J Neuropsychiatry Clin Neurosci (1994) 0.77
Clinical correlates of response to valproate in geriatric inpatients. Ann Clin Psychiatry (1998) 0.77
Propranolol in high doses increases plasma prolactin concentrations in male rats. Biol Psychiatry (1980) 0.77
Clinical correlates of valproate augmentation in refractory bipolar disorder. Ann Clin Psychiatry (1993) 0.77
Psychiatric diagnosis and risk for tardive dyskinesia. Arch Gen Psychiatry (1983) 0.77
Clinical differences between schizophrenic patients with and without large cerebral ventricles. J Clin Psychiatry (1983) 0.77
Schizophrenia-like illness following head injury. Psychosomatics (1981) 0.77
Clinical correlates of sulcal widening in chronic schizophrenia. Psychiatry Res (1983) 0.77
Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol (1991) 0.76
Sydenham's chorea and psychosis. Neuropsychobiology (1986) 0.76
Renaming schizophrenia: keeping up with the facts. Schizophr Res (2013) 0.76
The CATIE schizophrenia effectiveness trial. Schizophr Res (2005) 0.76
A placebo-controlled trial of valproate in tardive dyskinesia. Biol Psychiatry (1985) 0.76
Familial and sporadic schizophrenia: visual evoked potential differences. Biol Psychiatry (1988) 0.76
Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement. Brain Res Bull (1983) 0.76
Alcoholism secondary to essential tremor. J Clin Psychiatry (1982) 0.76
Right-hemisphere speech, callosal size, perinatal brain insult, and schizophrenia. Ann Neurol (1989) 0.76
A longitudinal survey of side effects in a lithium clinic. J Clin Psychiatry (1982) 0.75
Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer's disease. Biol Psychiatry (1990) 0.75
Brain and CSF volume differences in schizophrenic subtypes. Am J Psychiatry (1995) 0.75
Visual evoked potential correlates of positive/negative symptoms in schizophrenia. Biol Psychiatry (1990) 0.75
A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science (1979) 0.75
Neurological differences between paranoid and nonparanoid schizophrenia: part II. computerized tomographic findings. J Clin Psychiatry (1982) 0.75
Neurological differences between paranoid and nonparanoid schizophrenia: part III. neurological soft signs. J Clin Psychiatry (1982) 0.75
Tardive dyskinesia and depot fluphenazine. Br J Psychiatry (1979) 0.75